In his final months of life, a Mentor teen watched the Ohio State defensive end wear a "JBS Strong" armband in his honor at ...

Avacta is stepping up development of its peptide-drug conjugate (PDC), kicking off expansion cohorts in multiple tumor types ...

Now, I have stopped all school work entirely. If I only have around three years left to live, what's the point in A-levels?" ...

Stoke-on-Trent schoolgirl Melody Brown has undergone surgery to remove a cancerous tumour 'the size of an orange' which is ...

One Arkansas teen is sharing her story in hopes of showing others that despite having a rare but serious cancer, it can in ...

Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...

Alliance Global Partners initiated coverage of Intensity Therapeutics (INTS) with a Buy rating and $8.50 price target Intensity is developing ...

Nigel Burton explains what it feels like for a parent to be told their child has cancer, and how the charity came to his family’s aid during ...

The US FDA, Health Canada, European Medicines Authority, and the Australian Therapeutic Goods Administration authorized the Company's global, randomized Phase 3 study (INVINCIBLE-3) in Metastatic Soft ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

GeneTether Therapeutics Inc. (CSE: GTTX) today announced that it has changed its name to Rize Oncology Inc. (“Rize” or the “Company”). This rebranding reflects the Company's strategic shift towards ...

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...